Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mondo Minerals, now operating as Elementis Talc, is a leading global producer of high-purity talc products used across various industrial and life science sectors. The company is a significant supplier to the pharmaceutical industry, providing specialized talc that serves as an essential excipient in tablet production, glidants, and topical formulations. Its pharmaceutical-grade products are manufactured to meet stringent global standards, including USP, EP, and JP pharmacopeias. With a robust supply chain anchored by high-quality mines in Finland and advanced processing facilities in the Netherlands, the company ensures consistent mineral purity and performance. Following its acquisition by Elementis in 2018, Mondo Minerals has integrated its mineral expertise into a broader specialty chemicals portfolio to serve the global healthcare market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mondo Minerals.